Clinical Trials Directory

Trials / Sponsors / Takara Bio Inc.

Takara Bio Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingMulti-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Syno
Synovial Sarcomas
Phase 32026-01-05
Active Not RecruitingPhase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV
Phase 12017-09-25
CompletedStudy of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovia
Synovial Sarcoma
Phase 1 / Phase 22017-09-20
Active Not RecruitingStudy of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
Lymphoblastic Leukemia, Acute Adult
Phase 1 / Phase 22017-06-01
CompletedA Study of Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic
Melanoma Stage III, Melanoma Stage IV
Phase 22017-05-25
CompletedA Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions
Solid Tumor
Phase 12015-06-01
CompletedA Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Malignant Melanoma
Phase 22014-04-30
CompletedStudy of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superfici
Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast
Phase 12009-08-01